1334708-97-2

Upstream product

• 147807-58-7 4-(3'-chlorobenzyloxy)-benzoylhydrazine 
• 75-15-0 carbon disulfide 
• 1334708-96-1 N-[2-{4'-(3''-chlorobenzoyloxy)phenyl}-1,3,4-triazol-5-yl]thiourea 
• 1334708-95-0 2-{4'-(3''-chlorobenzoyloxy)phenyl}-5-amino-1,2,4-triazole 
• 1334708-92-7 2-{4'-(3''-chlorobenzoyloxy)phenyl}-5-amino-1,3,4-oxadiazole 
• 1334708-84-7 4-(3'-chlorobenzoyloxy)benzoylthiosemicarbazide 

Relevant academic research and scientific papers

Synthesis of thiazolo [3,2-b]-s-triazole, isomeric thiazolo [2,3-c]-s-triazole, thiazolo [3,2-b]-s-triazole-5 (6H)-one, imidazolo [2,3-b]-1,3,4-thiadiazol-5-one, 1,3,4-oxadiazolo [3,2-a]-s-triazine-5,7 (6H)-dithione and 1,3,4-triazolo [3,2-b]-triazine-5,7 (6H)-dithione as antifungal and antileishmanial agents

A new series of bridgehead nitrogen containing heterocyclic compounds like thiazolo [3,2-b]-s-triazole, isomeric thiazolo [2,3-c]-s-triazole, thiazolo [3,2-b]-s-triazole-5(6H)-one, imidazolo [2,3-i)]-1,3,4-thiadiazol-5-one, 1,3,4-oxadiazolo [3,2-a]-5-triazine -5,7 (6H) dithione and 1,3,4-triazolo [3,2-b]-s-triazine-5,7 (6H)-dithione have been synthesized and screened for their antimycotic and antileishmanial potential against human pathogenic fungi and Leishmania donovani.